FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

385099005: Cream (basic dose form)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1479361015 Cream en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3534583015 Cream (basic dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3635429014 A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. en Definition Active Entire term case sensitive (core metadata concept) SNOMED CT core
1459277015 Cream (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1479361015 Cream en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1479361015 Cream en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2660358016 Cream (qualifier value) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2660358016 Cream (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3534583015 Cream (basic dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3635429014 A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. en Definition Active Entire term case sensitive (core metadata concept) SNOMED CT core
7141000188111 crème fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
7141000188111 crème fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Is a Type of drug preparation false Inferred relationship Existential restriction modifier (core metadata concept)
A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Is a forme pharmaceutique pour usage transdermique et/ou cutané false Inferred relationship Existential restriction modifier (core metadata concept)
A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Is a Basic dose form with semi-solid state of matter (basic dose form) true Inferred relationship Existential restriction modifier (core metadata concept)
A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Has state of matter (attribute) Semi-solid true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Drug cream, 0,5% (substance) Is a False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Drug cream, 0,01% (substance) Is a False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Drug cream, 2,5% Is a False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Drug cream, 0,025% Is a False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Drug cream, 0,1% (substance) Is a False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Drug cream, 0,25% Is a False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Drug cream, 1% (substance) Is a False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Drug cream, 0,02% (substance) Is a False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Drug cream, 0,05% Is a False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Eye cream (product) Is a False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
crème buccale à libération conventionnelle Is a False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Cutaneous cream Is a False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Ear cream Is a False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Conventional release nasal cream (dose form) Is a False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Conventional release vaginal cream (dose form) Is a False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Rectal cream Is a False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Colloid sulfur 80 mg/g and resorcinol 20 mg/g cutaneous cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Stannous fluoride 0.4% cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Alpha tocopheryl acetate 50iu/g cream (substance) Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Nitrofurazone 0.2% cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Dienestrol 0.01% cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely nonoxinol 20 milligram/1 gram conventional release vaginal cream (clinical drug) Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Liquid paraffin+white soft paraffin cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Topical dimethicone cream (product) Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Halobetasol propionate 0.05% cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Sulfanilamide 15% cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Sodium fluoride 1.23% cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Sodium fluoride 1.2% cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Sodium fluoride 2.0% cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Heparinoid 0.3% cream (substance) Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Monobenzone 20% cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Methyl aminolevulinate 168mg/g topical cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Benzalkonium chloride 1 mg/g and dimeticone 220 mg/g cutaneous cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely eflornithine (as eflornithine monohydrate chloride) 115 milligram/1 gram conventional release cutaneous cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely hydroquinone 20 milligram/1 gram conventional release cutaneous cream (clinical drug) Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Tazarotene 0.05% cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Butenafine hydrochloride 1% cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Meclocycline sulfosalicylate 1% cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Gamolenic acid 20% cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely fluorouracil 10 milligram/1 gram conventional release cutaneous cream (clinical drug) Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Avobenzone 2%/ecamsule 3%/octocrilene 10%/titanium dioxide 5% topical cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Avobenzone 2%/ecamsule 2%/octocrilene 10%/titanium dioxide 2% topical cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Cetrimide 3 mg/g and dimeticone 1000 100 mg/g cutaneous cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Fluorouracil 5 mg/g cutaneous cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely docosanol 100 milligram/1 milliliter conventional release cutaneous cream (clinical drug) Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Adapalene 1 mg/g cutaneous cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Hydrous wool fat+zinc oxide 4/8% cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Oxiconazole nitrate 1% cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely methyl aminolevulinate (as methyl aminolevulinate hydrochloride) 160 milligram/1 gram conventional release cutaneous cream (clinical drug) Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Fusidic acid 20 mg/g cutaneous cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Benzocaine+triclosan 1/0.2% cream (substance) Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Benzoyl peroxide 10% cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Dimethicone+calamine+zinc oxide 20/1.5/7.5% cream (substance) Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Benzydamine hydrochloride 30 mg/g cutaneous cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Fluocinolone acetonide 250 microgram/g and neomycin sulfate 5 mg/g cutaneous cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Benzoyl peroxide 50 mg/g cutaneous cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely povidone iodine 50 milligram/1 gram conventional release cutaneous cream (clinical drug) Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Mafenide acetate 112mg cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Fluocinolone acetonide+clioquinol 0.025%/3% cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Urea+lactic acid 10/5% cream (substance) Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Diphenhydramine 2%/zinc acetate 0.1% topical cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely benzoyl peroxide 40 milligram/1 gram conventional release cutaneous cream (clinical drug) Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Evening primrose oil 20% cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Naftifine hydrochloride 1.0% cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Benzoyl peroxide 8% cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone+clotrimazole 0.05/1% cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Eflornithine hydrochloride 13.9% cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Tazarotene 0.1% cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Polynoxylin 100 mg/g cutaneous cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Benzalkonium chloride 100 microgram/g and cetrimide 2 mg/g cutaneous cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Azelaic acid 200 mg/g cutaneous cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Avobenzone 2%/ecamsule 3%/octocrilene 10% topical cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely benzoyl peroxide 50 milligram/1 gram and potassium hydroxyquinoline sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Avobenzone 2%/ecamsule 2%/octocrilene 10% topical cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Benzoic acid 60 mg/g and salicylic acid 30 mg/g cutaneous cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely calcipotriol 50 microgram/1 milliliter conventional release cutaneous cream (clinical drug) Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely cetrimide 10 milligram/1 gram conventional release cutaneous cream (clinical drug) Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Clorquinaldol 30 mg/g and hydrocortisone butyrate 1 mg/g cutaneous cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Miconazole nitrate 20 mg/g cutaneous cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Ketoconazole 20 mg/g cutaneous cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Imiquimod 5% cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Hydrocortisone 10 mg/g and urea 100 mg/g cutaneous cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely fusidic acid 20 milligram/1 gram and hydrocortisone acetate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely fluorouracil 50 milligram/1 gram conventional release cutaneous cream (clinical drug) Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Clioquinol 30 mg/g and hydrocortisone 10 mg/g cutaneous cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Mafenide acetate 85mg/g cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Ammonium lactate 12% cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely sulconazole nitrate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Bifonazole 10 mg/g cutaneous cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Dithranol 20 mg/g cutaneous cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Dithranol 30 mg/g cutaneous cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Econazole nitrate 10 mg/g and hydrocortisone 10 mg/g cutaneous cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely clocortolone pivalate 1 milligram/1 milliliter conventional release cutaneous cream (clinical drug) Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Dithranol 5 mg/g cutaneous cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely clotrimazole 10 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely hydrocortisone 10 milligram/1 gram and miconazole nitrate 20 milligram/1 gram conventional release cutaneous cream (clinical drug) Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely nystatin 100000 unit/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Dithranol 2.5 mg/g cutaneous cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Chlorhexidine hydrochloride 10 mg/g and nystatin 100000 unit/g cutaneous cream Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely tolnaftate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) Has manufactured dose form False A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. Inferred relationship Existential restriction modifier (core metadata concept)

Page 1 of 2 End

This concept is not in any reference sets

Back to Start